• Egemen Akgün, Fadime Mutlu Içduygu, Demet Şengül, Ebru Alp, Mehmet Alkanat, Ayşegül Çebi, and Tuncer Öztürk.
• Department of Medical Biology, Faculty of Medicine, Giresun University, Giresun, Turkiye.
• Turk J Med Sci. 2024 Jan 1; 54 (6): 121512221215-1222.

Background/AimTo investigate the association between the rs2267437, rs5751129 and rs132770 polymorphisms of the XRCC6 gene, which plays a role in repairing DNA double-strand breaks, and the risk of papillary thyroid carcinoma (PTC).Materials And MethodsThe study included 150 patients who had been diagnosed with PTC and 204 healthy controls. Genotyping of the SNPs was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).ResultsIn the rs2267437 polymorphism, individuals with the GG genotype had lower risk of PTC than those with the wild-type CC genotype (p = 0.037, 95% CI: 0.19-0.96, OR: 0.67). The combined genotypes CG+GG were related to a reduced risk of PTC compared to the wild-type CC genotype (p = 0.023, 95% CI: 0.40-0.94, OR: 0.61) in the recessive model (GC+GG vs. CC). In addition, a query of the genotype-tissue expression (GTEx) database showed that the rs2267437 polymorphism may alter the expression level of XRCC6 in whole blood (p = 0.0009) but not in thyroid tissue. There were no significant associations between the rs5751129 and rs132770 polymorphisms and PTC.ConclusionThis study demonstrated that rs2267437 polymorphism may have a protective effect against PTC in the Turkish population. However, the rs5751129 and rs132770 polymorphisms were not associated with the disease.© TÜBİTAK.

25 keywords...

hide…